The Organization and Function of the Toxoplasma Daughter Cell Scaffold
弓形虫子细胞支架的组织和功能
基本信息
- 批准号:10533770
- 负责人:
- 金额:$ 64.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-08 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAntiparasitic AgentsApicalCell MaturationCell NucleusCell membraneCellsCentrosomeComplexCullin ProteinsCytokinesisCytoplasmDataDaughterDefectDevelopmentDiseaseF Box DomainF-Box ProteinsFetal DevelopmentFutureGrowthGuanosine Triphosphate PhosphohydrolasesImmunocompromised HostInterphaseLifeMembraneModelingMothersNamesOrganellesParasitesPlasmodiumProcessProteinsProteomicsPublishingResearchRoleSkeletonStructureTestingToxoplasmaTrimethoprim-SulfamethoxazoleWorkcell motilitydaughter cellnew therapeutic targetnoveloligomycin sensitivity-conferring proteinpathogenprotein complexreceptorrecruitscaffoldscreeningsuperresolution microscopyubiquitin-protein ligase
项目摘要
Uncontrolled Toxoplasma growth is the primary mechanism by which the parasite causes
severe and life-threatening disease. The parasite replicates by a process termed endodyogeny,
where two daughter parasites form within a single mother. A key step in endodyogeny is formation
of the daughter cell inner membrane complex, which is an unique organelle that lies directly
underneath the plasma membrane and is required for parasite motility and replication. During
daughter cell development, the nascent IMC emerges from a complex named the daughter cell
scaffold (DCS). Despite its importance, the DCS is poorly characterized and few of its constituent
proteins are known. Here, we hypothesize that the Toxoplasma F-box protein, TgFBXO1, is a
critical component of the DCS. To test our hypothesis, we will determine: i) how TgFBXO1 is
targeted to the DCS, ii) how TgFBXO1 regulates inner membrane complex development and
organization, and iii) which TgFBXO1-interacting proteins are important for inner membrane
complex development. Together, these studies will provide in depth mechanistic detail for a
protein complex that is critical for growth of an important protozoan pathogen. Furthermore, they
were serve as a springboard for future studies aimed at developing novel anti-parasitic drugs that
function by targeting this complex.
不受控制的弓形虫生长是寄生虫引起
严重和危及生命的疾病。寄生虫通过一种称为内分泌的过程进行复制,
一个母亲体内会产生两个寄生虫女儿内膜异位症的关键步骤是形成
子细胞内膜复合体,这是一种独特的细胞器,
在质膜下,并且是寄生虫运动和复制所需的。期间
在子细胞发育过程中,新生的IMC从一个名为子细胞的复合体中出现
支架(DCS)。尽管它的重要性,DCS是穷人的特点,很少有其组成部分,
蛋白质已知。在这里,我们假设弓形虫F-box蛋白TgFBXO 1是一种
DCS的重要组成部分。为了检验我们的假设,我们将确定:i)TgFBXO 1是如何被
靶向DCS,ii)TgFBXO 1如何调节内膜复合物的发育,
组织,和iii)哪些TgFBXO 1相互作用蛋白对于内膜是重要的
复杂的发展。总之,这些研究将提供深入的机制细节,
一种对重要的原生动物病原体的生长至关重要的蛋白质复合物。而且他们
作为未来研究的跳板,旨在开发新的抗寄生虫药物,
以这个复杂的系统为目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ira J Blader其他文献
Ira J Blader的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ira J Blader', 18)}}的其他基金
Toxoplasma F-Box Protein Regulation of the Apicoplast
弓形虫 F-Box 蛋白对顶质体的调节
- 批准号:
10539694 - 财政年份:2022
- 资助金额:
$ 64.6万 - 项目类别:
Protist Oxygen Sensing in Human Disease Protist Oxygen Sensing in Human Disease
人类疾病中的原生生物氧传感 人类疾病中的原生生物氧传感
- 批准号:
10467358 - 财政年份:2022
- 资助金额:
$ 64.6万 - 项目类别:
Toxoplasma F-Box Protein Regulation of the Apicoplast
弓形虫 F-Box 蛋白对顶质体的调节
- 批准号:
10626164 - 财政年份:2022
- 资助金额:
$ 64.6万 - 项目类别:
Protist Oxygen Sensing in Human Disease Protist Oxygen Sensing in Human Disease
人类疾病中的原生生物氧传感 人类疾病中的原生生物氧传感
- 批准号:
10651752 - 财政年份:2022
- 资助金额:
$ 64.6万 - 项目类别:
Identification of F-Box Proteins in Toxoplasma
弓形虫中 F-Box 蛋白的鉴定
- 批准号:
9974899 - 财政年份:2020
- 资助金额:
$ 64.6万 - 项目类别:
The Organization and Function of the Toxoplasma Daughter Cell Scaffold
弓形虫子细胞支架的组织和功能
- 批准号:
9917284 - 财政年份:2020
- 资助金额:
$ 64.6万 - 项目类别:
The Organization and Function of the Toxoplasma Daughter Cell Scaffold
弓形虫子细胞支架的组织和功能
- 批准号:
10083185 - 财政年份:2020
- 资助金额:
$ 64.6万 - 项目类别:
The Organization and Function of the Toxoplasma Daughter Cell Scaffold
弓形虫子细胞支架的组织和功能
- 批准号:
10320439 - 财政年份:2020
- 资助金额:
$ 64.6万 - 项目类别:
Toxoplasma gondii Regulation of Host GABAergic Signaling
弓形虫对宿主 GABA 信号传导的调节
- 批准号:
9212770 - 财政年份:2016
- 资助金额:
$ 64.6万 - 项目类别:
Oxygen Sensing by the AIDS Opportunist Pathogen, Toxoplasma gondii
艾滋病机会病原体弓形虫的氧感应
- 批准号:
8923613 - 财政年份:2015
- 资助金额:
$ 64.6万 - 项目类别:
相似海外基金
Selective inhibitors of Heme Transporters as Antiparasitic Agents
作为抗寄生虫剂的血红素转运蛋白选择性抑制剂
- 批准号:
8901577 - 财政年份:2015
- 资助金额:
$ 64.6万 - 项目类别:
Simple, Selective Antimitotic Antiparasitic Agents
简单、选择性抗有丝分裂抗寄生虫药
- 批准号:
7086168 - 财政年份:2004
- 资助金额:
$ 64.6万 - 项目类别:
Simple, Selective Antimitotic Antiparasitic Agents
简单、选择性抗有丝分裂抗寄生虫药
- 批准号:
7245023 - 财政年份:2004
- 资助金额:
$ 64.6万 - 项目类别:
Simple, Selective Antimitotic Antiparasitic Agents
简单、选择性抗有丝分裂抗寄生虫药
- 批准号:
6813915 - 财政年份:2004
- 资助金额:
$ 64.6万 - 项目类别:
Simple, Selective Antimitotic Antiparasitic Agents
简单、选择性抗有丝分裂抗寄生虫药
- 批准号:
6909861 - 财政年份:2004
- 资助金额:
$ 64.6万 - 项目类别:
Antiparasitic Agents from Wild Primate Medicinal Plants
来自野生灵长类药用植物的抗寄生虫剂
- 批准号:
06044122 - 财政年份:1994
- 资助金额:
$ 64.6万 - 项目类别:
Grant-in-Aid for international Scientific Research
MORPHOLINO-ANTISENSE POLYMERS AS ANTIPARASITIC AGENTS
吗啉代反义聚合物作为抗寄生虫剂
- 批准号:
2069304 - 财政年份:1993
- 资助金额:
$ 64.6万 - 项目类别:














{{item.name}}会员




